Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anova Enterprises operates the AnovaOS™ platform, which connects sponsors, sites/physicians, and patients to accelerate clinical trial enrollment and compassionate use programs. The platform has supported the launch of studies such as the Phase 1/2a trial for DB107 in high-grade gliomas. It is recognized for improving patient access and streamlining regulatory processes in clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anova Enterprises.